Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02436668
Brief Title: Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)

First Submitted : May 4, 2015
First Submitted that Met QC Criteria : May 6, 2015
First Posted : May 7, 2015 (Estimate)

Results First Submitted : October 31, 2019
Results First Submitted that Met QC Criteria : October 20, 2020
Results First Posted : November 16, 2020

Last Update Submitted that Met QC Criteria : December 7, 2020
Last Update Posted : December 30, 2020